ISB News

New Details on Thyroid Cancer May Lead to More Precise Therapies

3 Bullets:

  • Papillary thyroid cancer represents 80 percent of all thyroid cancer cases.
  • Integrative analysis resulted in the detection of significant molecular alterations not previously reported in the disease.
  • ISB researchers identified microRNAs which may lead to more precise therapy.

By Lisa Iype

Papillary thyroid cancer (PTC) is the most common type of thyroid cancer, accounting for 80 percent of all cases. As part of The Cancer Genome Atlas (TCGA) project, ISB researchers helped to analyze the largest cohort of PTC samples studied to date. The low background mutation density of PTC and the large number of patients in the study enabled the researchers to detect significant molecular alterations that were not associated with the disease before.

Title: Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Publication: Cell
Authors: The Cancer Genome Atlas Research Network
Link: http://www.cell.com/cell/pdf/S0092-8674%2814%2901238-0.pdf

Researchers analyzed DNA sequence, gene expression, microRNA expression, protein expression, and DNA methylation profiles of PTCs to study the disease. ISB researchers played a significant role in exploring associations among these different types of data. They detected potential involvement of certain microRNAs, which are small non-protein-coding RNA molecules that can regulate the activities of other genes, in less differentiated subgroups of PTC, which may lead to more precise surgical and medical therapy.

Studying the disease from a systems perspective demonstrated that the subgroups of PTC differ in their molecular alterations as well as signaling and differentiation characteristics. With this knowledge, the researchers are proposing a refined classification of PTC to reflect these differences and to better inform clinical management of the disease.

Read more about ISB’s role in TCGA.

About Dr. Lisa Iype: Lisa is a bioinformatics scientist in the Shmulevich Lab at ISB. She contributed to the integrative analysis represented in this TCGA Research Network paper.

Recent Articles

  • COVID-19 Vaccines and Boosters Are Essential for Maternal-Fetal Health

    In light of the recent FDA and CDC decision to approve two updated messenger RNA COVID-19 booster shots, it is imperative to alert the pregnant population of the importance and effectiveness of these vaccines and boosters. 

  • Spotlight on ISB Education graphic

    2022-23 School Year ISB Education Highlights

    From planning, creating and executing workshops for educators to forging new relationships to elevate students, the ISB Education team has been in high gear. Each month throughout the 2022-2023 academic year, we will highlight some of the top projects the team is working on.

  • 2023 ISB Virtual Microbiome Series

    2023 ISB Virtual Microbiome Series Registration Now Open!

    On October 11-13, 2023, ISB will host a virtual course and symposium on how the ecology of our guts protects us from pathogens. Both events are virtual and free. The intended audience for these events are graduate students, postdocs, principal investigators, industry scientists, educators, clinicians, or any other variety of microbiome-curious person from across the globe.